CN1358187A - 新的化合物 - Google Patents

新的化合物 Download PDF

Info

Publication number
CN1358187A
CN1358187A CN00809484A CN00809484A CN1358187A CN 1358187 A CN1358187 A CN 1358187A CN 00809484 A CN00809484 A CN 00809484A CN 00809484 A CN00809484 A CN 00809484A CN 1358187 A CN1358187 A CN 1358187A
Authority
CN
China
Prior art keywords
compound
alkyl
amino
tert
group
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN00809484A
Other languages
English (en)
Chinese (zh)
Inventor
M·林肖滕
M·波拉
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Publication of CN1358187A publication Critical patent/CN1358187A/zh
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
    • C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D211/34—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/132—Amines having two or more amino groups, e.g. spermidine, putrescine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C211/00—Compounds containing amino groups bound to a carbon skeleton
    • C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
    • C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
    • C07C211/09—Diamines
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Hydrogenated Pyridines (AREA)
  • Peptides Or Proteins (AREA)
CN00809484A 1999-05-03 2000-05-03 新的化合物 Pending CN1358187A (zh)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE99015729 1999-05-03
SE9901572A SE9901572D0 (sv) 1999-05-03 1999-05-03 New compounds

Publications (1)

Publication Number Publication Date
CN1358187A true CN1358187A (zh) 2002-07-10

Family

ID=20415425

Family Applications (1)

Application Number Title Priority Date Filing Date
CN00809484A Pending CN1358187A (zh) 1999-05-03 2000-05-03 新的化合物

Country Status (23)

Country Link
US (2) US7354895B1 (enExample)
EP (1) EP1180099A1 (enExample)
JP (1) JP4270759B2 (enExample)
KR (1) KR20020010631A (enExample)
CN (1) CN1358187A (enExample)
AR (1) AR028826A1 (enExample)
AU (1) AU4447100A (enExample)
BR (1) BR0010256A (enExample)
CA (1) CA2371215A1 (enExample)
CZ (1) CZ20013931A3 (enExample)
EE (1) EE200100573A (enExample)
HK (1) HK1042493A1 (enExample)
HU (1) HUP0202379A3 (enExample)
IL (1) IL145953A0 (enExample)
IS (1) IS6141A (enExample)
MX (1) MXPA01011043A (enExample)
NO (1) NO20015374L (enExample)
PL (1) PL356140A1 (enExample)
SE (1) SE9901572D0 (enExample)
SK (1) SK15662001A3 (enExample)
TR (1) TR200103144T2 (enExample)
WO (1) WO2000066550A1 (enExample)
ZA (2) ZA200108967B (enExample)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111110837A (zh) * 2020-01-06 2020-05-08 中国人民解放军陆军军医大学 一种羧肽酶抑制剂在制备预防重症致死性轮状病毒感染药物中的应用
CN113395996A (zh) * 2019-02-08 2021-09-14 阿斯利康(瑞典)有限公司 精氨酸酶抑制剂及其使用方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0014615A (pt) * 1999-09-14 2002-06-18 Meiji Seika Kaisha Derivado de ácido fosfÈnico que apresenta atividade inibidora contra carboxipeptidase b
HRP20030103A2 (en) * 2000-08-17 2003-04-30 Pfizer Substituted imidazoles as tafia inhibitors
SE0103272D0 (sv) * 2001-09-28 2001-09-28 Astrazeneca Ab Chemical compounds
US6713496B2 (en) 2002-01-22 2004-03-30 Pfizer Inc 3-(imidazolyl)-2-alkoxypropanoic acids
IL162677A0 (en) * 2002-01-22 2005-11-20 Pfizer 3-(Imidazolyl)-2-alkoxypropanoic acids as tafia inhibitors
MXPA04005940A (es) 2002-01-22 2004-09-13 Pfizer Acidos 3-(imidazolil)-2-aminopropanoicos.
EP2204373A1 (en) 2002-03-21 2010-07-07 Bayer Schering Pharma Aktiengesellschaft Phosphonic acid as Plasma Carboxypeptidase B Inhibitors
JPWO2010050525A1 (ja) 2008-10-29 2012-03-29 大正製薬株式会社 ＴＡＦＩａ阻害活性を有する化合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2516307A (en) * 1949-01-06 1950-07-25 Gen Mills Inc Vinyl resins plasticized with cyano esters
US4560680A (en) * 1982-03-15 1985-12-24 E. R. Squibb & Sons, Inc. Aminoalkyl and related substituted phosphinic acid angiotensin converting enzyme inhibitors
US4849414A (en) * 1986-06-11 1989-07-18 E. R. Squibb & Sons, Inc. Substituted aminoalkanoylaminoalkyl phosphonate angiotensin converting enzyme inhibitors
FR2610951B1 (fr) * 1987-02-17 1989-05-05 Aerospatiale Armature tissee pour materiau composite
IL86951A (en) * 1987-07-06 1996-07-23 Procter & Gamble Pharma Methylene phosphonoalkylphosphinates and pharmaceutical preparations containing them
NZ246456A (en) * 1991-12-17 1997-03-24 Procter & Gamble Pharma Use of bone active phosphonate and a parathyroid hormone to prepare medicaments for a thirty day treatment regimen for osteoporosis
US5550119A (en) * 1995-03-02 1996-08-27 Ciba-Geigy Corporation Phosphono substituted tetrazole derivatives as ECE inhibitors
US5672592A (en) * 1996-06-17 1997-09-30 Guilford Pharmaceuticals Inc. Certain phosphonomethyl-pentanedioic acid derivatives thereof
JP3440305B2 (ja) * 1997-04-02 2003-08-25 高砂香料工業株式会社 ７−（ｎ−置換アミノ）−２−フェニルヘプタン酸 エステル誘導体及び該誘導体の製造方法
UA58543C2 (uk) 1997-02-27 2003-08-15 Амерікан Ціанамід Компані N-гідрокси-2-(алкіл-, арил-, або гетероарилсульфаніл, -сульфініл або -сульфоніл)-3-заміщені алкіл-, арил- або гетероариламіди як інгібітори матричних металопротеїназ
AR023819A1 (es) * 1999-05-03 2002-09-04 Astrazeneca Ab FORMULACIoN FARMACEUTICA, KIT DE PARTES Y UTILIZACION DE DICHA FORMULACION
SE9901573D0 (sv) * 1999-05-03 1999-05-03 Astra Ab New compounds
BR0014615A (pt) * 1999-09-14 2002-06-18 Meiji Seika Kaisha Derivado de ácido fosfÈnico que apresenta atividade inibidora contra carboxipeptidase b

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113395996A (zh) * 2019-02-08 2021-09-14 阿斯利康(瑞典)有限公司 精氨酸酶抑制剂及其使用方法
CN113395996B (zh) * 2019-02-08 2024-05-28 阿斯利康(瑞典)有限公司 精氨酸酶抑制剂及其使用方法
US12435097B2 (en) 2019-02-08 2025-10-07 Astrazeneca Ab Arginase inhibitors and methods of use thereof
CN111110837A (zh) * 2020-01-06 2020-05-08 中国人民解放军陆军军医大学 一种羧肽酶抑制剂在制备预防重症致死性轮状病毒感染药物中的应用
CN111110837B (zh) * 2020-01-06 2022-11-25 中国人民解放军陆军军医大学 一种羧肽酶抑制剂在制备预防重症致死性轮状病毒感染药物中的应用

Also Published As

Publication number Publication date
NO20015374D0 (no) 2001-11-02
CZ20013931A3 (cs) 2002-04-17
MXPA01011043A (es) 2002-06-04
JP4270759B2 (ja) 2009-06-03
US7354895B1 (en) 2008-04-08
SE9901572D0 (sv) 1999-05-03
SK15662001A3 (sk) 2002-09-10
HK1042493A1 (zh) 2002-08-16
IL145953A0 (en) 2002-11-10
IS6141A (is) 2001-11-01
BR0010256A (pt) 2002-02-13
NO20015374L (no) 2001-11-02
WO2000066550A1 (en) 2000-11-09
US20060079484A1 (en) 2006-04-13
JP2002543179A (ja) 2002-12-17
EP1180099A1 (en) 2002-02-20
ZA200108966B (en) 2003-01-30
PL356140A1 (en) 2004-06-14
AU4447100A (en) 2000-11-17
CA2371215A1 (en) 2000-11-09
KR20020010631A (ko) 2002-02-04
HUP0202379A2 (hu) 2002-12-28
EE200100573A (et) 2003-02-17
US7423012B2 (en) 2008-09-09
AR028826A1 (es) 2003-05-28
ZA200108967B (en) 2003-01-30
TR200103144T2 (tr) 2004-11-22
WO2000066550A8 (en) 2001-01-25
HUP0202379A3 (en) 2003-04-28

Similar Documents

Publication Publication Date Title
CN1099425C (zh) 新的肽衍生物
US5990083A (en) Multicatalytic protease inhibitors
CN1358174A (zh) 新的化合物
CN1136278A (zh) 双膦酸盐与生长激素促分泌素的组合
CN1198818C (zh) 具有释放生长激素特性的化合物
EP0910573A1 (en) New amino acid derivatives and their use as thrombin inhibitors
HU204286B (en) Process for producing renin-inhibiting dipeptide derivatives and pharmaceutical compositions containing them as active components
KR100347646B1 (ko) 매트릭스메탈로프로테아제억제제
CN1266427A (zh) 新的脒基衍生物及其作为凝血酶抑制剂的用途
CN1358187A (zh) 新的化合物
HU206704B (en) Process for producing piperidine derivatives of amino acids and pharmaceutical compositions containing them
CN1423638A (zh) 用作前胶原c－蛋白酶抑制剂的噁(二)唑基异羟肟酸
CN1127488C (zh) 具有生长激素释放特性的化合物
CN1038103A (zh) 环烷基取代的戊二酰胺利尿剂和其制备方法
CN1307588A (zh) 具有生长激素释放特性的化合物
CN1642975A (zh) 有弹性蛋白酶抑制活性的杂环化合物及其中间体
CN1127512C (zh) α－酮酯和α－酮酰胺的酰化烯醇衍生物
JPH02117693A (ja) アミノメチルペプチド、その製造方法及びその薬剤としての使用
HK1071893A (en) Pyrane derivatives as both ace-and nep-inhibitors
HK1080487B (en) Heterocyclic compounds having elastase-inhibiting activity and intermediates thereof
HK1016614A (en) ACYLATED ENOL DERIVATIVES OF α-KETOESTERS AND α-KETOAMIDES
JP2009137864A (ja) 医薬組成物

Legal Events

Date Code Title Description
C06 Publication
C10 Entry into substantive examination
PB01 Publication
SE01 Entry into force of request for substantive examination
C02 Deemed withdrawal of patent application after publication (patent law 2001)
WD01 Invention patent application deemed withdrawn after publication